Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients
Top Cited Papers
- 29 November 2006
- journal article
- research article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 180 (1-2) , 63-70
- https://doi.org/10.1016/j.jneuroim.2006.06.029
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- ROLE OF C5A IN INFLAMMATORY RESPONSESAnnual Review of Immunology, 2005
- A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cellsBlood, 2003
- Treatment of IgM antibody associated polyneuropathies using rituximabJournal of Neurology, Neurosurgery & Psychiatry, 2003
- Maintenance of Serological Memory by Polyclonal Activation of Human Memory B CellsScience, 2002
- Intrathecal IgG synthesis: marker of progression in multiple sclerosis patientsActa Neurologica Scandinavica, 2002
- A study of oligoclonal band negative multiple sclerosis.Journal of Neurology, Neurosurgery & Psychiatry, 1996
- Immunoglobulins promote remyelination in the central nervous systemAnnals of Neurology, 1990
- Temporal invariance and clonal uniformity of brain and cerebrospinal IgG, IgA, and IgM in multiple sclerosis.The Journal of Experimental Medicine, 1986
- Immunoglobulin G, A, and M—Clonal restriction in multiple sclerosis cerebrospinal fluid and serum—Analysis by two-dimensional electrophoresisClinical Immunology and Immunopathology, 1985
- Rating neurologic impairment in multiple sclerosisNeurology, 1983